(Q44449961)

3 December 2017

Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes (English)

1 reference

3 December 2017

0 references

1 reference

Hirokazu Tsukahara

1

1 reference

3 December 2017

KyouchiI Sekine

2

1 reference

3 December 2017

Mayumi Uchiyama

3

1 reference

3 December 2017

Hisako Kawakami

4

1 reference

3 December 2017

Ikue Hata

5

1 reference

3 December 2017

Yukiko Todoroki

6

1 reference

3 December 2017

Masahiro Hiraoka

7

1 reference

3 December 2017

Masayuki Kaji

8

1 reference

3 December 2017

Tohru Yorifuji

9

1 reference

3 December 2017

Toru Momoi

10

1 reference

3 December 2017

Kazuhiro Yoshihara

11

1 reference

3 December 2017

Masatoshi Beppu

12

1 reference

3 December 2017

Mitsufumi Mayumi

13

1 reference

3 December 2017

language of work or name

English

0 references

publication date

21 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

54

1 reference

3 December 2017

3

1 reference

3 December 2017

419-424

1 reference

https://scigraph.springernature.com/pub.10.1203/01.pdr.0000076662.72100.74

3 December 2017

0 references

cites work

Advanced glycosylation end products in diabetic renal and vascular disease

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Determination of urinary and serum pentosidine and its application to elder patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Determination of urinary pyrraline by solid-phase extraction and high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Reactive oxygen species-induced molecular damage and its application in pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Protein-bound acrolein: potential markers for oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Current status of acrolein as a lipid peroxidation product

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Increased oxidative stress in childhood atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

A 1-hour enzyme-linked immunosorbent assay for quantitation of acrolein- and hydroxynonenal-modified proteins by epitope-bound casein matrix method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Advanced glycation end products in children with chronic renal failure and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Role of oxidative stress in advanced glycation end product-induced mesangial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Endothelial dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Endothelial dysfunction in children with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Carbonyl stress in the pathogenesis of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Advanced glycation end products in adolescents and young adults with diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with Type 1 diabetes with no clinical vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Oxidative protein damage in early stage Type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000076662.72100.74

10.1203/01.PDR.0000076662.72100.74

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 December 2017

0 references

1 reference